Tim Guilliams appears in Brel Digital’s verified company_founders attribution for Healx based in United Kingdom in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.
Company context (from the verified Healx profile): Cambridge AI biotech discovering and advancing rare-disease therapies through Healnet and a growing clinical-stage portfolio
Why the company matters (verified company field): Healx demonstrates how AI drug-discovery platforms transition from repurposing hypotheses to owned clinical-stage assets — its 2025 Vuja De Sciences transaction added a second oncology program and shows rare-disease AI vendors becoming hybrid biotechs, not just software licensors.
Official company website on file: https://healx.io. Readers should consult that site and the Sources section for primary evidence.
Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.